New research in AD, Parkinson’s, and mood disorders.
An ambitious new research goal seeks to better understand how the brain works. Will the project succeed, and what will it actually show?
By Zac Haughn, Senior Associate Editor
A new study says damaged blood vessels loaded with amyloid worsen cognitive impairment in Alzheimer’s disease. What are the implications?
By Q&A with Costantino Iadecola, MD
The latest data report from the association highlights the current and future burden of AD and outlines proposed new approaches to diagnosis.
Researchers continue to focus on the role of biomarkers in diagnosis and prognosis.
By Pravin Khemani, MD
A majority of individuals age 50 or older could potentially avoid shingles or post-herpetic neuralgia.
By Stephen K. Tyring, MD, PhD
This disabling complication of upper extremity hemodialysis access is under diagnosed.
By Valentina Rodriguez, MD; Dipal Shah, MD; Vanya Grover, DO; Steven Mandel, MD; David Fox, MD; and Nicky Bhatia, MD
The Committee for Medicinal Products for Human Use (CHMP) in the European Union (EU) has endorsed Tecfidera.
An excerpt from exclusive on-line content from Practical Neurology.